In the analysis of XRCC3 Thr241Met polymorphism, women with homozygote expression (Met/Met genotype) of 241Met allele had three times increased risk of breast cancer (OR = 2.77, 95% CI = 1.26–6.11; P = 0.009). The gene discussed is XRCC3; the disease is breast carcinoma.